-
APLS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Apellis Pharmaceuticals (APLS)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 398.24 mm | 398.24 mm | 398.24 mm | 398.24 mm | 398.24 mm | 398.24 mm |
Cash burn (monthly) | (no burn) | 4.61 mm | 18.95 mm | 20.65 mm | (no burn) | 17.09 mm |
Cash used (since last report) | n/a | 20.50 mm | 84.38 mm | 91.94 mm | n/a | 76.10 mm |
Cash remaining | n/a | 377.73 mm | 313.86 mm | 306.29 mm | n/a | 322.14 mm |
Runway (months of cash) | n/a | 82.0 | 16.6 | 14.8 | n/a | 18.8 |
13F holders | Current |
---|---|
Total holders | 267 |
Opened positions | 46 |
Closed positions | 42 |
Increased positions | 93 |
Reduced positions | 92 |
13F shares | Current |
---|---|
Total value | 3.25 tn |
Total shares | 129.84 mm |
Total puts | 1.08 mm |
Total calls | 3.84 mm |
Total put/call ratio | 0.3 |
Largest owners | Shares | Value |
---|---|---|
Wellington Management | 15.57 mm | $448.95 bn |
Morningside Venture Investments | 12.81 mm | $0.00 |
EcoR1 Capital | 11.89 mm | $342.93 bn |
Avoro Capital Advisors | 11.11 mm | $320.44 bn |
Vanguard | 9.82 mm | $283.08 bn |
BlackRock | 6.19 mm | $178.59 bn |
Deep Track Capital | 4.40 mm | $126.91 bn |
STT State Street | 4.04 mm | $116.54 bn |
JPM JPMorgan Chase & Co. | 3.88 mm | $112.04 bn |
MS Morgan Stanley | 3.39 mm | $97.76 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
29 Jan 25 | Mark Jeffrey DeLong | Common Stock | Sell | Dispose S | No | No | 29.5236 | 365 | 10.78 k | 84,308 |
29 Jan 25 | Francois Cedric | Common Stock | Sell | Dispose S | No | No | 29.5236 | 2,824 | 83.37 k | 415,695 |
29 Jan 25 | Deschatelets Pascal | Common Stock | Sell | Dispose S | No | No | 29.5236 | 826 | 24.39 k | 1,147,716 |
29 Jan 25 | Jeffrey Eisele | Common Stock | Sell | Dispose S | No | No | 29.5236 | 278 | 8.21 k | 55,312 |
29 Jan 25 | Karen Lewis | Common Stock | Sell | Dispose S | No | No | 29.5236 | 364 | 10.75 k | 70,251 |